Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07024940 · ClinicalTrials.gov registry record · NA
Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance
A NA study of Exercise Performance and Coffee, sponsored by St. Louis University.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07024940: Recruiting NA study of Exercise Performance and Coffee, sponsored by St. Louis University.
NCT07024940 is a NA study of Exercise Performance and Coffee that is actively recruiting participants, run by St. Louis University. The registered enrollment target is 12 participants, below the 31-participant average among 7 other Exercise Performance trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07024940, a NA study of Exercise Performance and Coffee, is actively recruiting participants, sponsored by St. Louis University.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are conducting a study to see how a commercial pre-workout supplement, coffee, and water affect how well people perform. The study is conducted across four visits. The first visit is to assess the participants, and the next three visits are for testing. Each participant will drink a randomly assigned beverage 45 minutes before testing. Throughout the study, the participants will complete three testing days-each at least three days apart-so they can try all three drinks. The first test is the Wingate test, where the participants pedal as fast as they can for 30 seconds against a set resistance. The second test is a 1-mile treadmill run/walk on an incline, where the participant tries to complete the distance as fast as possible. The third test measures reaction time using light-up buttons to see how quickly a participant responds by touching them. These tests will help determine if any of the drinks improve performance. The results can help people choose the best drink for their workouts or races.
Primary Outcome
The primary outcome measured is the change in anaerobic power measured by a 30-second all-out effort on a cycle ergometer using the Wingate testing. This test will determine whether the interventions confer any performance benefit compared to the placebo.
Conditions Studied
Interventions
- OTHER Ethiopian Coffee
- DIETARY_SUPPLEMENT Supplement
- OTHER Water (Placebo)
Study Locations (1)
Missouri
- Saint Louis University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-04-25 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT07024940 shows while recruiting
NCT07024940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 31-participant average among 7 other Exercise Performance trials with a reported enrollment target (61% lower).
The record links to 3 conditions, with Exercise Performance appearing as the primary indexed condition, and to 3 interventions - of which Ethiopian Coffee is the first listed.
NCT07024940 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07024940 about?
NCT07024940 is a clinical study titled "Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance". The investigators are conducting a study to see how a commercial pre-workout supplement, coffee, and water affect how well people perform. The study is conducted across four visits. The first visit is to assess the participants, and the next three visits are for testing. Each participant will drink ...
What is the current status of trial NCT07024940?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-04-25. Estimated completion is 2026-09-01.
What conditions does trial NCT07024940 study?
This clinical trial studies the following conditions: Exercise Performance, Coffee, Anthocyanins.
What interventions are being tested in trial NCT07024940?
The interventions under investigation include: Ethiopian Coffee (OTHER), Supplement (DIETARY_SUPPLEMENT), Water (Placebo) (OTHER).
Who is sponsoring clinical trial NCT07024940?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07024940 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise Performance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
RECRUITING · NA
-
Creatine Supplementation At Simulated Altitude
RECRUITING · NA
-
Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators
RECRUITING · NA
-
Does Sildenafil Increase Exercise Performance in Air Pollution?
COMPLETED · NA
-
Potato Ingestion and Time-trial Performance
COMPLETED · NA
-
Effects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular Performance
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI